FIGS (NYSE:FIGS) Sets New 12-Month Low at $4.35

FIGS, Inc. (NYSE:FIGS)’s stock price reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $4.35 and last traded at $4.40, with a volume of 1683432 shares traded. The stock had previously closed at $4.53.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on FIGS. Roth Mkm reduced their price objective on shares of FIGS from $7.50 to $6.75 and set a “buy” rating on the stock in a research note on Friday, May 10th. Telsey Advisory Group reiterated a “market perform” rating and set a $6.00 target price on shares of FIGS in a research note on Thursday, June 13th. Oppenheimer lowered shares of FIGS from an “outperform” rating to a “market perform” rating in a research note on Friday, March 8th. Barclays lowered their price objective on FIGS from $7.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Friday, March 1st. Finally, The Goldman Sachs Group cut their price objective on shares of FIGS from $4.85 to $4.25 and set a “sell” rating for the company in a report on Tuesday, April 23rd. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, FIGS has an average rating of “Hold” and a consensus target price of $5.30.

FIGS Trading Down 2.4 %

The company has a market cap of $752.42 million, a P/E ratio of 40.19, a price-to-earnings-growth ratio of 60.40 and a beta of 1.42. The company has a 50 day moving average price of $5.17 and a 200-day moving average price of $5.71.

FIGS (NYSE:FIGS) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. The company had revenue of $119.29 million during the quarter, compared to analysts’ expectations of $117.38 million. FIGS had a return on equity of 6.12% and a net margin of 4.07%. FIGS’s revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.01 EPS. Equities analysts expect that FIGS, Inc. will post 0.03 earnings per share for the current year.

Insider Transactions at FIGS

In other FIGS news, insider Heather L. Hasson sold 28,614 shares of FIGS stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $4.89, for a total transaction of $139,922.46. Following the transaction, the insider now directly owns 468,870 shares of the company’s stock, valued at approximately $2,292,774.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders have sold 31,644 shares of company stock worth $155,648. Insiders own 22.30% of the company’s stock.

Hedge Funds Weigh In On FIGS

Hedge funds have recently bought and sold shares of the company. Barclays PLC increased its position in FIGS by 62.6% in the 3rd quarter. Barclays PLC now owns 85,715 shares of the company’s stock valued at $507,000 after buying an additional 33,003 shares in the last quarter. Swiss National Bank increased its position in shares of FIGS by 1.1% during the third quarter. Swiss National Bank now owns 280,700 shares of the company’s stock valued at $1,656,000 after acquiring an additional 3,100 shares during the last quarter. Janney Montgomery Scott LLC purchased a new stake in shares of FIGS during the 3rd quarter valued at $78,000. Aigen Investment Management LP purchased a new stake in FIGS during the third quarter worth about $247,000. Finally, Algert Global LLC grew its position in shares of FIGS by 121.2% during the 3rd quarter. Algert Global LLC now owns 278,260 shares of the company’s stock valued at $1,642,000 after acquiring an additional 152,460 shares during the period. Institutional investors own 92.21% of the company’s stock.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.